Journal of the Egyptian National Cancer Institute : Impact Factor & More
eISSN: 2589-0409pISSN: 1110-0362
Open AccessShare this on:
Key Metrics
CiteScore 
2.1
H-Index
26
SJR
Q3Oncology
SNIP
0.67
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Journal of the Egyptian National Cancer Institute
Journal of the Egyptian National Cancer Institute Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Continuous publication |
| Publication Time | 11 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Cairo University, National Cancer Institute |
| Frequency | Continuous publication |
| Publication Start Year | 2011 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 11 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Journal of the Egyptian National Cancer Institute ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Journal of the Egyptian National Cancer Institute
Pooled safety profiles of bispecific antibodies targeting PD-1/CTLA-4 or PD-1/VEGF in non-small cell lung cancer: a systematic review and single-arm meta-analysis
- 5 Aug 2026
- Journal of the Egyptian National Cancer Institute
MSA U-Net: a multi-scale attention-enhanced network for automatic segmentation of uterine lymph nodes in MRI images
- 3 Aug 2026
- Journal of the Egyptian National Cancer Institute
Real-world efficacy and safety of CDK4/6 inhibitors plus endocrine therapy in HR+/HER2\u2009\u2212\u2009metastatic breast cancer: a single-institution experience
- 28 Jul 2026
- Journal of the Egyptian National Cancer Institute
The promising role of engineered T lymphocytes in immunotherapy for high-grade serous ovarian carcinoma: a review of mechanisms, clinical landscape, and future strategies
- 27 Jul 2026
- Journal of the Egyptian National Cancer Institute
Clinical efficacy and safety outcomes of anlotinib therapy in sarcoma: a systematic review and meta-analysis
- 24 Jul 2026
- Journal of the Egyptian National Cancer Institute
Efficacy and safety of antibody-drug conjugates in HER2-positive and HER2-low advanced gastric cancer: a systematic review and update
- 22 Jul 2026
- Journal of the Egyptian National Cancer Institute
Pooled safety profiles of bispecific antibodies targeting PD-1/CTLA-4 or PD-1/VEGF in non-small cell lung cancer: a systematic review and single-arm meta-analysis
- 5 Aug 2026
- Journal of the Egyptian National Cancer Institute
MSA U-Net: a multi-scale attention-enhanced network for automatic segmentation of uterine lymph nodes in MRI images
- 3 Aug 2026
- Journal of the Egyptian National Cancer Institute
Real-world efficacy and safety of CDK4/6 inhibitors plus endocrine therapy in HR+/HER2\u2009\u2212\u2009metastatic breast cancer: a single-institution experience
- 28 Jul 2026
- Journal of the Egyptian National Cancer Institute
The promising role of engineered T lymphocytes in immunotherapy for high-grade serous ovarian carcinoma: a review of mechanisms, clinical landscape, and future strategies
- 27 Jul 2026
- Journal of the Egyptian National Cancer Institute
Clinical efficacy and safety outcomes of anlotinib therapy in sarcoma: a systematic review and meta-analysis
- 24 Jul 2026
- Journal of the Egyptian National Cancer Institute
Efficacy and safety of antibody-drug conjugates in HER2-positive and HER2-low advanced gastric cancer: a systematic review and update
- 22 Jul 2026
- Journal of the Egyptian National Cancer Institute
FAQs on Journal of the Egyptian National Cancer Institute
How long has Journal of the Egyptian National Cancer Institute been actively publishing? 
What is the publishing frequency of Journal of the Egyptian National Cancer Institute?
How many articles did Journal of the Egyptian National Cancer Institute publish last year?
What is the eISSN & pISSN for Journal of the Egyptian National Cancer Institute?
What is Citescore for Journal of the Egyptian National Cancer Institute?
What is the H Index for Journal of the Egyptian National Cancer Institute ?
What is SNIP score for Journal of the Egyptian National Cancer Institute?
What is the SJR for Journal of the Egyptian National Cancer Institute?
Who is the publisher of Journal of the Egyptian National Cancer Institute?
